12 Most Undervalued Stocks to Invest In

7. MetLife, Inc. (NYSE:MET)

On May 21, 2026, Morgan Stanley analyst Bob Huang raised the firm’s price target on MetLife, Inc. (NYSE:MET) to $93 from $89 and maintained an Overweight rating on the shares. Huang said Q1 results were “generally strong” for life insurance companies and expects earnings momentum to continue through the rest of 2026, supported by international business momentum and continued improvements in mortality.

JPMorgan analyst Jimmy Bhullar also raised the firm’s price target on MetLife, Inc. (NYSE:MET) to $96 from $95 and maintained an Overweight rating on the shares. JPMorgan raised estimates following the company’s Q1 report.

Earlier in May, MetLife, Inc. (NYSE:MET) reported Q1 adjusted EPS of $2.42, ahead of the consensus estimate of $2.27. Revenue totaled $19.07B, below the consensus estimate of $19.42B. President and CEO Michel Khalaf said MetLife delivered “exceptional performance” in the first quarter, with adjusted EPS up 23% and broad top-line growth. Khalaf added that the company is making progress in year two of New Frontier through disciplined execution and capital deployment that balances business investment with shareholder returns.

MetLife, Inc. (NYSE:MET) provides insurance, annuities, employee benefits, and asset management services worldwide.

1281292 - 11759070 - 1